How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Ryan Eichler holds a B.S.B.A with a concentration in Finance from Boston University. He has held positions in, and has deep experience with, expense auditing, personal finance, real estate, as well as ...

Should developing economies follow the United States and China by building national champions? Geopolitics is rapidly changing the landscape of world trade. The policy environment of just a few ...

Waiting for your refund is a test of patience, especially if you're using the money to pay rent, credit card bills or other necessities, as nearly 70% of filers say they will, according to a recent ...

Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...